Primary Citation PubMed: 23301637
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer.
(2013) Int J Mol Sci 14
PubMed: 23771019 | PubMedCentral: PMC3709796 | DOI: 10.3390/ijms140612496
To validate the on-target binding of these compounds, X-ray structures were resolved with some of the developed inhibitors bound to the AR AF2 or the BF3 sites (PDBs: 2YLP, 2YLO, 2YHD, 4HLW).
Publication Year: 2013
PubMed ID is not available.
Published in 2015
Furthermore, several structures of the inhibitors within the intended AR AF2 and BF3 target sites were resolved by X-ray crystallography and deposited in the Protein Data Bank [PDB:4HLW, PDB:2YLO, PDB... 2YHD, PDB:3ZQT, PDB:2YLP, PDB:2YLQ].
Publication Year: 2015
The RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics:
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.